1. Home
  2. RELL vs GBIO Comparison

RELL vs GBIO Comparison

Compare RELL & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

N/A

Current Price

$10.97

Market Cap

149.6M

Sector

Technology

ML Signal

N/A

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.43

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELL
GBIO
Founded
1947
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.6M
35.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RELL
GBIO
Price
$10.97
$5.43
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$10.67
AVG Volume (30 Days)
52.9K
40.1K
Earning Date
01-06-2026
11-05-2025
Dividend Yield
2.19%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$209,791,000.00
$15,270,000.00
Revenue This Year
$4.72
N/A
Revenue Next Year
$14.93
N/A
P/E Ratio
$903.34
N/A
Revenue Growth
6.17
N/A
52 Week Low
$7.57
$3.00
52 Week High
$15.51
$13.00

Technical Indicators

Market Signals
Indicator
RELL
GBIO
Relative Strength Index (RSI) 57.20 51.71
Support Level $10.75 $5.22
Resistance Level $11.47 $5.64
Average True Range (ATR) 0.42 0.25
MACD 0.11 0.05
Stochastic Oscillator 75.00 67.19

Price Performance

Historical Comparison
RELL
GBIO

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: